Tufts Research on Oversight Performance: Assessment and Impact
Date: September 27th, 2018
Time: 10am PT (1pm ET)
Duration: 60 minutes


Tufts CSDD has been researching the outsourcing environment for the past 20 years. However, this new study puts a spotlight on a relatively new area of focus around Oversight. The research aimed to measure and quantify perceived effectiveness in the critical outsourcing function.  As organizations take a hard look at their current practices the research findings provide valuable insight and actionable areas for improvement

Join Ken Getz of Tufts CSDD as he discusses the results of the study and their implications. Specific areas covered include:

  •   Approaches deployed for oversight
  •   Overall effectiveness of these practices
  •   Plans to improve oversight methods

The session will include a summary of the results from this groundbreaking survey that will inform the viewer of the myriad of outsourcing models used, outsourcing hierarchy utilized, and challenges faced due to inconsistency and lack of management involvement.

Speakers will also share their perspective on where the industry is headed and ways to overcome Oversight challenges including transparency, risk, and compliance.

Featured Speakers


Getz May 2014 (1).jpg

Ken Getz, Director of Sponsored Research and Associate Professor at the Tufts Center for the Study of Drug Development, Tufts University School of Medicine

Kenneth A. Getz is the Director of Sponsored Research and an associate professor at the Tufts Center for the Study of Drug Development, Tufts University School of Medicine where he directs research programs on drug development management strategy and practice including protocol design and execution; outsourcing; investigative site management; and patient recruitment and retention. He is the chair of CISCRP – a nonprofit organization that he founded to educate and raise public and patient awareness of the clinical research enterprise.  Ken is also the founder of CenterWatch, a leading publisher in the clinical trials industry.

A well-known speaker at conferences, symposia, universities, investor meetings and corporations, Ken has published extensively in peer-review journals, books and in the trade press.  He is the author of two nationally recognized books for patients and their advocates and the recipient of several awards for innovation and scholarship.  Ken has held board appointments in the private and public sectors including serving on the Institute of Medicine's Clinical Research Roundtable, the Drug Information Association, the Consortium to Examine Clinical Research Ethics, the Clinical Trials Transformation Initiative, the Metrics Champion Consortium, and the WIRB-Copernicus Group. He is on the editorial boards of Pharmaceutical Medicine and Therapeutic Innovation and Regulatory Science, and writes a bi-monthly column in Applied Clinical Trials that was nominated for a Neal Award. Ken has also been nominated twice for Tufts University’s Distinguished Service award and was inducted as a DIA Fellow in 2015.

Ken holds an MBA from the J.L. Kellogg Graduate School of Management at Northwestern University and a bachelor’s degree, Phi Beta Kappa, from Brandeis University. Prior to founding CenterWatch in 1994, Ken worked for over seven years in management consulting where he assisted biopharmaceutical companies develop and implement business strategies to improve clinical development performance.



Julie Peacock, Clinical Intelligence Expert, Comprehend

Closely aligned with customers and the sales organization, Julie focuses on enabling prospects and customers on Comprehend’s Clinical Intelligence solutions. She manages go to market strategy, sales enablement, and product marketing.

Prior to Comprehend, Julie spent 18 years at Oracle Corporation in the enterprise application space where she managed strategy, field enablement and launch activities for a series of BtoB solutions. Julie holds a bachelor’s degree in Marketing from Auburn University.